Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Back to the future with phenotypic screening.

ACS chemical neuroscience - 16 Jul 2014

Prior Marguerite, Chiruta Chandramouli, Currais Antonio, Goldberg Josh, Ramsey Justin, Dargusch Richard, Maher Pamela A, Schubert David

Abstract excerpt

There are no disease-modifying drugs for any old age associated neurodegenerative disease or stroke. This is at least in part due to the failure of drug developers to recognize that the vast majority of neurodegenerative diseases arise from a confluence of multiple toxic insults that accumulate during normal aging and interact with genetic and environmental risk factors. Thus, it is unlikely that the current...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phenotype
Share to Neuroprotective Agents
Share to Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bioinformatics and Genomic Networks

Share to Computational Drug Discovery Methods

Share to Drug Evaluation, Preclinical

Share to Neurodegenerative Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 24902068
DOI: 10.1021/cn500051h
PMCID: PMC4102969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Back to the future with phenotypic screening.PMID 24902068Read ↗

Phenotypic screens targeting neurodegenerative diseases.Semantic proximity Read ↗

Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.Semantic proximity Read ↗

An Alternative Approach To Drug Discovery For Alzheimer’s Disease DementiaSemantic proximity Read ↗

Expanding therapeutic opportunities for neurodegenerative diseases: A perspective on the important role of phenotypic screening.Semantic proximity Read ↗

Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease.Semantic proximity Read ↗

The future of genetic research on neurodegeneration.Semantic proximity Read ↗

Approaches for discovering anti-prion compounds: lessons learned and challenges ahead.Semantic proximity Read ↗

More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease.Semantic proximity Read ↗

Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.Semantic proximity Read ↗

Cell death assays for neurodegenerative disease drug discoverySemantic proximity Read ↗

The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods.Semantic proximity Read ↗

The Resurrection of Phenotypic Drug DiscoverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.